Halozyme Therapeutics Inc (FRA:RV7)
€ 93.44 +0.64 (+0.69%) Market Cap: 10.74 Bil Enterprise Value: 12.39 Bil PE Ratio: 32.16 PB Ratio: 85.56 GF Score: 92/100

Halozyme Therapeutics Inc (FRA:RV7) Transcripts

  • 1